• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EL.EN. ELECTRONIC ENGINEERING S.P.A. DEKA SMARTXIDE2

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EL.EN. ELECTRONIC ENGINEERING S.P.A. DEKA SMARTXIDE2 Back to Search Results
Model Number M103P1
Device Problem Adverse Event Without Identified Device or Use Problem
Event Date 08/23/2017
Event Type  Injury  
Manufacturer Narrative

The actual device was not returned to the manufacturer for evaluation. Us importer's authorized service personnel checked the actual device unit at customer site on december 11th, 2017. The technician found, prior to any servicing operation, the device to be working properly within specifications ((b)(4)). The investigation has been performed by interrogating the doctor that have performed the treatment, dr. (b)(6). The operator of the device (site doctor) stated that the treatment procedure was performed per the clinical reference guide protocol. Moreover site's doctor did indicate the patient has a history of cystitis, long standing urethral pain prior to the laser procedures, was on numerous medications for +25 years (such as elmron, amytripyline, loprezol, atosvastatin, gabapentin, valium, oxycodone, pro-biotics, calcium, vitamin d) , and was looking for urethra pain management treatments. However the patient declined to follow up with the customer site, so there is no additional information regarding the treatment from this event. The investigation carried out did not conclude that a design deficiency or device malfunctioning was responsible for causing the event. Rather, it could be assumed that there was a pre-existing patient's condition that contributed to the event. Device working within specifications. No remedial action required. This initial report is to be considered as final report, unless fda has further questions.

 
Event Description

The patient contacted the manufacturer through the general contact mail in date (b)(6) 2017 reporting of an adverse event following a treatment with smartxide2 laser medical device (ref: m103p1 - s/n: (b)(4)) manufactured by el. En. Electronic engineering (b)(4). The patient described that she saw an urologist because she was having burning in her urethra following 4 laser treatment performed by doctor (b)(6) at the clinic "advanced urology manhasset" placed at (b)(6). That patient saw 2 different urologist and received medical intervention from them after the laser treatments. The manufacturer have involved its us importer, (b)(4) company located in (b)(4), in order to carry the investigation in the united states. The us importer has been informed the same day that the manufacturer became aware of the event ((b)(6) 2017). (b)(4). Also represents us distributor and service center for el. En. Electronic engineering (b)(4) medical devices. The us importer have contacted both patient and physician in order to deeply investigate on this issue. Unfortunately the patient did not agreed to release her clinical data for evaluation. This incident was classified as a reportable event by the us importer because the patient had medical intervention following the treatment. The us importer, (b)(4), submitted an mdr initial report to fda for this event (#1222993-2017-00050) on december, 15, 2017. This medwatch report is in response to fda report mw5073422 submitted to fda by the patient in date (b)(6) 2017 and received by fda in date (b)(6) 2017. In conformity to 21 cfr part 803. 22(a) el. En. Will submit only one mdr because the information incoming from different sources (the patient and fda) concerns the same event. We, the manufacturer of device, became aware of the event on (b)(6) 2017 by email from the patient and, according to 21 cfr part 803. 50(b)(2), submitted to fda an own mdr report in order to conduct an investigation of the event and to obtain missing or incomplete information provided by the importer.

 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameDEKA SMARTXIDE2
Type of DeviceDEKA SMARTXIDE2
Manufacturer (Section D)
EL.EN. ELECTRONIC ENGINEERING S.P.A.
via baldanzese 17
calenzano, firenze 50041
ITALY 50041
Manufacturer (Section G)
EL.EN. ELECTRONIC ENGINEERING S.P.A.
via baldanzese 17
calenzano, firenze 50041
ITALY 50041
Manufacturer Contact
andrea checchi
via baldanzese 17
calenzano, firenze  50041
ITALY   50041
MDR Report Key7125417
Report Number3001431138-2017-00009
Device Sequence Number1
Product CodeGEX
Report Source Manufacturer
Source Type OTHER
Reporter Occupation Patient
Remedial Action Other
Type of Report Initial
Report Date 12/18/2017
1 Device Was Involved in the Event
1 Patient Was Involved in the Event
Date FDA Received12/18/2017
Is This An Adverse Event Report? Yes
Is This A Product Problem Report? No
Device Operator Health Professional
Device MODEL NumberM103P1
Device Catalogue NumberM103P1
Was Device Available For Evaluation? No
Is The Reporter A Health Professional? No
Was the Report Sent to FDA? No
Event Location No Information
Date Manufacturer Received11/20/2017
Was Device Evaluated By Manufacturer? Device Not Returned To Manufacturer
Date Device Manufactured04/11/2016
Is The Device Single Use? No
Is this a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse

Patient TREATMENT DATA
Date Received: 12/18/2017 Patient Sequence Number: 1
-
-